Similarly, in the study from Rodriguez-Garcia et al., infusion of FRβ-specific CAR-T cells resulted in depletion of FRβ+ TAMs and controlled tumor progression in ovarian cancer, melanoma and colon adenocarcinoma (204). Here, FOLR2 is linked to neoplasm.